These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30280197)

  • 1. An RGD small-molecule integrin antagonist induces detachment-mediated anoikis in glioma cancer stem cells.
    Paolillo M; Galiazzo MC; Daga A; Ciusani E; Serra M; Colombo L; Schinelli S
    Int J Oncol; 2018 Dec; 53(6):2683-2694. PubMed ID: 30280197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells.
    Russo MA; Paolillo M; Sanchez-Hernandez Y; Curti D; Ciusani E; Serra M; Colombo L; Schinelli S
    Int J Oncol; 2013 Jan; 42(1):83-92. PubMed ID: 23174862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells.
    Maubant S; Saint-Dizier D; Boutillon M; Perron-Sierra F; Casara PJ; Hickman JA; Tucker GC; Van Obberghen-Schilling E
    Blood; 2006 Nov; 108(9):3035-44. PubMed ID: 16835373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
    Niibori-Nambu A; Midorikawa U; Mizuguchi S; Hide T; Nagai M; Komohara Y; Nagayama M; Hirayama M; Kobayashi D; Tsubota N; Takezaki T; Makino K; Nakamura H; Takeya M; Kuratsu J; Araki N
    PLoS One; 2013; 8(5):e59558. PubMed ID: 23704872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single cell tracking assay reveals an opposite effect of selective small non-peptidic α5β1 or αvβ3/β5 integrin antagonists in U87MG glioma cells.
    Ray AM; Schaffner F; Janouskova H; Noulet F; Rognan D; Lelong-Rebel I; Choulier L; Blandin AF; Lehmann M; Martin S; Kapp T; Neubauer S; Rechenmacher F; Kessler H; Dontenwill M
    Biochim Biophys Acta; 2014 Sep; 1840(9):2978-87. PubMed ID: 24810979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
    Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
    Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin inhibition promotes atypical anoikis in glioma cells.
    Silginer M; Weller M; Ziegler U; Roth P
    Cell Death Dis; 2014 Jan; 5(1):e1012. PubMed ID: 24457956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
    Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
    BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
    Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
    Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoliquiritigenin inhibits the proliferation and induces the differentiation of human glioma stem cells.
    Lin Y; Sun H; Dang Y; Li Z
    Oncol Rep; 2018 Feb; 39(2):687-694. PubMed ID: 29251326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule integrin antagonists in cancer therapy.
    Paolillo M; Russo MA; Serra M; Colombo L; Schinelli S
    Mini Rev Med Chem; 2009 Oct; 9(12):1439-46. PubMed ID: 19929817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrins in glioblastoma: Still an attractive target?
    Paolillo M; Serra M; Schinelli S
    Pharmacol Res; 2016 Nov; 113(Pt A):55-61. PubMed ID: 27498157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma.
    Kesanakurti D; Chetty C; Rajasekhar Maddirela D; Gujrati M; Rao JS
    Cell Death Dis; 2012 Dec; 3(12):e445. PubMed ID: 23254288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in integrin expression and signaling within human breast cancer cells.
    Taherian A; Li X; Liu Y; Haas TA
    BMC Cancer; 2011 Jul; 11():293. PubMed ID: 21752268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells.
    Berghauser Pont LM; Kleijn A; Kloezeman JJ; van den Bossche W; Kaufmann JK; de Vrij J; Leenstra S; Dirven CM; Lamfers ML
    PLoS One; 2015; 10(5):e0127058. PubMed ID: 25993039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitronectin-activated αvβ3 and αvβ5 integrin signalling specifies haematopoietic fate in human pluripotent stem cells.
    Shen J; Zhu Y; Zhang S; Lyu S; Lyu C; Feng Z; Hoyle DL; Wang ZZ; Cheng T
    Cell Prolif; 2021 Apr; 54(4):e13012. PubMed ID: 33656760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells.
    Talukdar S; Pradhan AK; Bhoopathi P; Shen XN; August LA; Windle JJ; Sarkar D; Furnari FB; Cavenee WK; Das SK; Emdad L; Fisher PB
    Proc Natl Acad Sci U S A; 2018 May; 115(22):5768-5773. PubMed ID: 29760085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.